Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „combination“
Suchtreffer
Begriffe & Kennungen
Braftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In patients treated with encorafenib 300 mg in combina
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In patients treated with encorafenib 300 mg in combina
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In patients treated with encorafenib 300 mg in combina
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In patients treated with encorafenib 300 mg in combina
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In patients treated with encorafenib 300 mg in combina
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In patients treated with encorafenib 300 mg in combina
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In patients treated with encorafenib 300 mg in combina
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In the population treated with encorafenib 300 mg in c
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination The incidence of increased transaminases in patients t
Eintrag öffnenBraftovi · 4.8 · Encorafenib with cetuximab and FOLFOX combination In the pooled EC+FOLFOX population, diarrhoea was observed i
Eintrag öffnenBraftovi · 4.8 · Hypertension Hypertension was reported when encorafenib was used in combination with binimetinib in melanoma a
Eintrag öffnenBraftovi · 4.8 · Left ventricular dysfunction LVD was reported when encorafenib is used in combination with binimetinib in mela
Eintrag öffnenBraftovi · 4.8 · The safety of encorafenib (300 mg orally once daily) in combination with binimetinib (45 mg orally twice daily
Eintrag öffnenBraftovi · 4.8 · The safety of encorafenib (300 mg orally once daily) in combination with cetuximab (dosed as per its SmPC) was
Eintrag öffnenBraftovi · 4.8 · The safety of encorafenib (300 mg orally once daily) in combination with cetuximab and FOLFOX was evaluated in
Eintrag öffnenBraftovi · 4.8 · The safety of encorafenib (450 mg orally once daily) in combination with binimetinib (45 mg orally twice daily
Eintrag öffnenBraftovi · 4.8 · Venous thromboembolism VTE was reported when encorafenib is used in combination with binimetinib in melanoma a
Eintrag öffnenBraftovi · 4.8 · When encorafenib was used at a dose of 300 mg once daily in combination with binimetinib 45 mg twice daily (Co
Eintrag öffnenBrimonidintartrat-Timololmaleat-Wirkstoffkombination
Eintrag öffnenBrintellix · 4.5 · Reversible, non-selective MAOI (linezolid) The combination of vortioxetine with a weak reversible and non-sele
Eintrag öffnen